Stocks · Healthcare · Medical - Care Facilities
Addus HomeCare Corporation ADUS
$111.27 -0.38% Close, Oct 2, 2026 · NASDAQ · Market cap $2.08B
Inexpensive vs sectorLow risk
Next earnings report: Nov 2, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Earnings beat analyst estimates in each of the last 14 quarters (average surprise over the last four: +3.5%).
- The shares trade at 19.5× trailing earnings, lower than 95% of the company's own readings over the past five years.
- The stock is in an uptrend: above its 200-day average for 64 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 38%
- EPS growth (TTM, YoY)Top 37%
- FCF growth (TTM, YoY)Top 24%
- Revenue growth, 3-year CAGRTop 41%
- Revenue growth accelerationBottom 29%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 18%
- Gross marginBottom 21%
- Operating marginTop 26%
- Cash conversion (OCF / net income)Bottom 48%
- Accruals (lower is better)Bottom 34%
- Net debt / EBITDA (lower is better)Top 37%
- Interest coverTop 12%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 10%
- Free-cash-flow yieldTop 11%
- EBITDA / enterprise valueTop 13%
- Sales / enterprise valueTop 16%
- P/E vs own 5-year history (lower is better)Top 15%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 36%
- 6-month returnTop 38%
- 1-year return vs S&P 500Bottom 40%
- Distance from 52-week highTop 16%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 50%
- Consecutive EPS beatsTop 2%
- Share of analysts rating BuyTop 43%
- Upside to consensus price targetBottom 18%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 3%
- Maximum drawdown, 3 yearsTop 8%
- Beta vs S&P 500 (lower is better)Top 7%
- Net debt / EBITDA (lower is better)Top 37%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 19.6% | 15.9% | ↓ |
| EPS growth (YoY) | 22.1% | 25.8% | ↑ |
| Gross margin | 32.6% | 32.4% | ↓ |
| Operating margin | 9.1% | 10.0% | ↑ |
| FCF margin | 7.4% | 10.4% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 15.9% | 19.6% | ↓ | Top 38% |
| EPS growth (TTM, YoY) | 25.8% | 22.1% | ↑ | Top 37% |
| Gross margin | 32.4% | 32.6% | ↓ | Bottom 21% |
| Operating margin | 10.0% | 9.1% | ↑ | Top 26% |
| Net margin | 7.1% | 6.5% | ↑ | — |
| Free-cash-flow margin | 10.4% | 7.4% | ↑ | — |
| Return on invested capital | 8.5% | — | Top 18% | |
| Revenue growth, 3-year CAGR | 14.4% | — | Top 41% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.54×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -3.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.6%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -14.0 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 0.06×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 14.9×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.17%
- Shareholder yield
- -0.17%
- Share count change, 1 year
- +0.7%
- Share count change, 3-year CAGR
- +4.3%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 14
- Beats in the last 8 reports
- 8 of 8
- Average EPS surprise, last 4
- +3.5%
- Average 2-day reaction, last 8
- +1.1%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $122.33
- Target vs current price
- +9.9%
- Analysts with a rating
- 16
- Share rating Buy or Strong Buy
- 81%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 3, 2026 | +1.8% | +1.1% | +3.6% | +0.1% | — |
| May 4, 2026 | +6.6% | +0.6% | +0.0% | -10.2% | +19.7% |
| Feb 23, 2026 | +3.5% | +1.9% | -10.3% | -14.0% | -19.8% |
| Nov 3, 2025 | +2.0% | +1.8% | -3.3% | +3.4% | -12.9% |
| Aug 4, 2025 | +2.8% | +1.9% | +5.0% | +9.7% | +15.7% |
| May 5, 2025 | +6.8% | -0.6% | +5.6% | +5.9% | +2.7% |
| Feb 24, 2025 | +2.2% | -0.4% | -12.3% | -17.8% | +1.7% |
| Nov 4, 2024 | +1.6% | +2.1% | +1.0% | -2.5% | -0.9% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 3, 2026 | $1.73 | $1.70 | +1.8% | $377.4M |
| May 4, 2026 | $1.62 | $1.52 | +6.6% | $363.5M |
| Feb 23, 2026 | $1.77 | $1.71 | +3.5% | $372.1M |
| Nov 3, 2025 | $1.56 | $1.53 | +2.0% | $362.3M |
| Aug 4, 2025 | $1.49 | $1.45 | +2.8% | $349.4M |
| May 5, 2025 | $1.42 | $1.33 | +6.8% | $337.7M |
| Feb 24, 2025 | $1.38 | $1.35 | +2.2% | $297.1M |
| Nov 4, 2024 | $1.30 | $1.28 | +1.6% | $289.8M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 19.5× | 27.9× | 5th | Top 10% |
| P/E (forward) | 15.8× | — | — | — |
| EV / EBITDA | 12.5× | — | — | Top 13% |
| EV / Sales | 1.41× | — | — | Top 16% |
| Free-cash-flow yield | 7.37% | — | — | Top 11% |
| Earnings yield | 5.12% | — | — | Top 10% |
P/E over the past five years
Range 18.2× – 39.5× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -4.0%
- Earnings per share growth (TTM)
- +25.8%
- Change in P/E multiple
- -22.5%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 64
- 50-day average slope (20 days)
- +3.0%
- 200-day average slope (20 days)
- +0.1%
- Distance from 50-day average
- -4.7%
- Distance from 200-day average
- +5.3%
- RSI (14)
- 38.0
- Relative volume
- 0.96×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 23.5%
- Volatility vs own 5-year history
- 6th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.27
- Correlation with S&P 500
- 0.14
- Current drawdown from 1-year high
- -9.4%
- Maximum drawdown, 3 years
- -34.9%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 22, 2021 | Feb 23, 2022 | -44.9% | 274 days | 620 days (Aug 13, 2024) |
| Jan 21, 2025 | Jun 3, 2026 | -34.9% | 343 days | Not yet recovered |
| Nov 3, 2020 | Nov 19, 2020 | -12.6% | 12 days | 18 days (Dec 16, 2020) |
| Aug 23, 2024 | Nov 18, 2024 | -11.5% | 60 days | 40 days (Jan 17, 2025) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $2.08B
- P/E (TTM)
- 19.5
- EPS, diluted (TTM)
- $5.70
- Revenue (TTM)
- $1.48B
- 52-week range
- $87.95 – $124.44
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $864.5M | $951.1M | $1.06B | $1.15B | $1.42B |
| Gross profit | $269.8M | $299.7M | $339.9M | $375.0M | $461.9M |
| Operating income | $65.9M | $68.7M | $91.0M | $102.7M | $138.6M |
| Net income | $45.1M | $46.0M | $62.5M | $73.6M | $95.9M |
| EPS (diluted) | $2.81 | $2.84 | $3.83 | $4.23 | $5.21 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $289.8M | $297.1M | $337.7M | $349.4M | $362.3M | $373.1M | $363.6M | $377.4M |
| Net income | $20.2M | $19.5M | $21.2M | $22.1M | $22.8M | $29.8M | $25.1M | $27.6M |
| EPS (diluted) | $1.10 | $1.07 | $1.16 | $1.20 | $1.24 | $1.61 | $1.36 | $1.49 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $39.5M | $105.1M | $112.2M | $116.4M | $111.5M |
| Capital expenditure | -$4.6M | -$8.3M | -$9.5M | -$6.0M | -$7.7M |
| Free cash flow | $34.8M | $96.8M | $102.8M | $110.4M | $103.8M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $1.1M | $2.5M | $319,000 | $179.0M | $2.5M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $99.6M
- Total assets
- $1.46B
- Total liabilities
- $308.3M
- Total debt
- $108.8M
- Net debt
- $9.3M
- Shareholders’ equity
- $1.15B
As of Jun 30, 2026 (filed Aug 4, 2026).
Short interest
- Shares sold short
- 879,964
- Days to cover
- 4.45
- Change vs previous report
- -1.7%
FINRA short interest, settlement date Sep 15, 2026.